Edwards Lifesciences Corp
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 115,004 | 0.1% | 1,346,608 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 76,654 | 0.1% | 980,106 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 72,003 | 0.1% | 993,453 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 95,126 | 0.1% | 1,284,949 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 124,567 | 0.1% | 1,887,644 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 190,233 | 0.2% | 2,059,442 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 196,485 | 0.2% | 2,056,143 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 59,689 | 0.0% | 782,795 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 50,262 | 0.0% | 725,451 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 62,168 | 0.0% | 659,128 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 54,441 | 0.0% | 658,104 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 51,363 | 0.0% | 686,575 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 53,463 | 0.0% | 644,427 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 56,088 | 0.0% | 588,536 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 70,302 | 0.0% | 597,829 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 61,404 | 0.0% | 473,983 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 65,936 | 0.1% | 582,424 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 62,766 | 0.1% | 606,025 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 51,486 | 0.0% | 615,568 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 55,845 | 0.1% | 612,138 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 52,406 | 0.1% | 656,564 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 45,081 | 0.0% | 664,029 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 42,757 | 0.0% | 226,682 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 45,683 | 0.0% | 195,822 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 7,918 | 0.0% | 106,761 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 7,002 | 0.0% | 106,465 | 12/31/2013 |